The significance of the question is not only basic, but also lies in the potential use of GSTM2C or its derivatives as drugs to reduce excess Ca2+ release in juvenile cardiomyopathies with arrhythmia attributed to high diastolic Ca2+ levels due to excess Ca2+ leak through RyR2. This evidence concerns the gene RYR2 and Arrhythmia.